A tube shunt is also the preferred surgical procedure for certain subtypes of glaucoma, such as neovascular glaucoma. Neovascular glaucoma is a type of secondary angle closure glaucoma in which ...
The analysis noted a trend toward the increasing popularity of minimally invasive glaucoma surgery (MIGS) procedures. “We ...
A TODDLER is at risk of blindness due to a rare condition that means her eyes won’t stop growing – and has left her crying ...
According to the company, its ViaLase Laser combines state-of-the-art femtosecond laser technology with micron-level image ...
[5] Both pericardium and dura matter are expensive. [5] The use of gamma-irradiated cornea (VisionGraft) for the coverage of a glaucoma tube shunt was recently described as allowing for both ...
[32,33] In addition, defining glaucoma control primarily from an IOP ... The optimal location of the GDD tube in endothelial keratoplasty eyes has not yet been specifically studied, and may ...
Aretria Bice was born with big blue eyes - but she is now at risk of going blind after being diagnosed with an incredibly ...
Over 700,000 people in the UK have glaucoma and it is the leading cause of irreversible blindness worldwide. The condition occurs when the cells in the eye that help you see (called retinal ...
Glaucoma is one of the leading causes of visual impairment and blindness. According to statistics from the Hospital Authority, in Hong Kong, three out of every 100 individuals aged over 40 suffer ...
Glaucoma, often called the silent thief of sight, is a group of eye diseases that cause irreversible optic nerve damage, leading to progressive vision loss and potential blindness if untreated.
Alcon has bought up Belkin Vision and its laser device for treating glaucoma. The deal includes an upfront transfer of $81 million, including about $65 million in cash—plus the opportunity for ...
Glaucoma is a disease caused by pressure within the eye. Over time, it can lead to vision loss or even blindness. In the U.S., about 3 million people are affected by it. There is no cure, but ...